Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2009, p. 931-936, Vol. 75, No. 4
0099-2240/09/$08.00+0 doi:10.1128/AEM.02186-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

*
Nick Wierckx,1,2,
R. G. Maaike Westerhof,1,
Johannes H. de Winde,2,3 and
Harald J. Ruijssenaars1,2
TNO Quality of Life, Business Unit Food and Biotechnology Innovations, Julianalaan 67, 2628 BC Delft, The Netherlands,1 B-Basic, Julianalaan 67, 2628 BC Delft, The Netherlands,2 Department of Biotechnology, Delft University of Technology, Julianalaan 67, 2628 BC Delft, The Netherlands3
Received 22 September 2008/ Accepted 26 November 2008
|
|
|---|
|
|
|---|
An example of an industrially relevant but extremely toxic aromatic is p-hydroxystyrene (4-vinyl phenol) (23). This compound is widely used as a monomer for the production of various polymers that are applied in resins, inks, elastomers, and coatings. Ben-Bassat et al. (2, 3, 23) reported p-hydroxystyrene production from glucose in Escherichia coli. In this strain, phenylalanine/tyrosine ammonia lyase (PAL/TAL; encoded by pal) from Rhodotorula glutinis and p-coumaric acid decarboxylase (PDC; encoded by pdc) from Lactobacillus plantarum were introduced for the conversion of L-tyrosine into p-hydroxystyrene via p-coumarate. The maximum concentration of p-hydroxystyrene was limited to 3.3 mM due to the toxicity of the product to the E. coli host (3, 23). To alleviate product toxicity, a two-phase fermentation with 2-undecanone as the extractant was performed. This approach resulted in a modest 14.2 mM p-hydroxystyrene in the organic phase and 0.5 mM p-hydroxystyrene in the water phase (2). Toxicity-related adverse effects on p-hydroxystyrene production may also be avoided by dividing the whole process into three stages: production of L-tyrosine from glucose by E. coli, conversion of L-tyrosine into p-coumarate by immobilized PAL-overexpressing E. coli cells, and chemical decarboxylation of p-coumarate into p-hydroxystyrene (29).
In this report, we address and strongly enhance the bio-based production of p-hydroxystyrene from glucose by employing the solvent-tolerant P. putida S12 as a host. Previously, two strains, P. putida S12 C3 (19) and P. putida S12 TPL3 (38), have been constructed for the production of the L-tyrosine-derived aromatics p-coumarate and phenol, respectively. These strains were highly optimized for aromatics production, resulting in a heavily increased metabolic flux toward L-tyrosine. Therefore, they are suitable platform strains for the production of other L-tyrosine-derived aromatics (33). The bifunctional enzyme PAL/TAL (EC 4.3.1.25) from Rhodosporidium toruloides and the enzyme PDC (EC 4.1.1.-) from L. plantarum were introduced into these strains to allow the conversion of L-tyrosine into p-hydroxystyrene (Fig. 1). These minor modifications resulted in an efficient biocatalyst for the production of the value-added compound p-hydroxystyrene from glucose.
![]() View larger version (23K): [in a new window] |
FIG. 1. Schematic overview of the biochemical pathway for p-hydroxystyrene production. TAL, tyrosine ammonia lyase; FCS, feruloyl-coenzyme A synthetase. The cross indicates the disruption of fcs, disabling p-coumarate degradation.
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains and plasmids used in this study
|
Analytical methods.
Cell densities were determined at 600 nm with an Ultrospec 10-cell density meter (Amersham Biosciences). An OD600 of 1 corresponds to 0.49 g liter–1 of cell dry weight (CDW). Glucose and organic acids were analyzed by ion chromatography (Dionex ICS3000 system) as described by Meijnen et al. (15). The p-coumarate, p-hydroxystyrene, and t-cinnamate concentrations were analyzed by high-performance liquid chromatography (Agilent 1100 system) using a Zorbax SB-C18 column (length, 5 cm; inside diameter, 4.6 mm; particle size, 3.5 µm) and a diode array detector. For analysis of aromatic compounds in aqueous solutions, 25% of acetonitrile in KH2PO4 buffer (50 mM, pH 2, 1% acetonitrile) was used as eluant at a flow of 1.5 ml min–1 for 4.5 min. For analysis of p-hydroxystyrene in 1-decanol, the eluant was 50% acetonitrile in MilliQ at a flow of 1.5 ml min–1 for 2.5 min. The samples of p-hydroxystyrene in the 1-decanol phase were diluted 100-fold in acetonitrile before analysis. The total p-hydroxystyrene concentration in the two-phase fed-batch cultures was calculated as follows (36): ctot = (caq x Vaq + cdec x Vdec) x Vtot–1, where ctot, caq, and cdec are, respectively, the total p-hydroxystyrene concentration and the concentrations in the aqueous and the 1-decanol phases. Vtot, Vaq, and Vdec are, respectively, the total liquid volume and the volumes of the aqueous and the 1-decanol phases.
DNA techniques.
Plasmids were introduced into P. putida S12 by electroporation using a Gene Pulser electroporation device (Bio-Rad). The targeted gene disruption of the fcs gene in P. putida S12 strain 427 was performed as described by Nijkamp et al. (19). The gene replacement vector for the smo gene, pJQsmo::km, was created from pJQ200SK (24) with primers 1 to 4 listed in Table 2, and gene replacement was performed as described previously (33). The kanamycin resistance gene was amplified from plasmid pTnMod-KmO (6) using primers 5 and 6 (Table 2). pJQsmo::km was introduced in P. putida S12 C3 by triparental mating using E. coli HB101 RK2013 (8) as the mobilizing strain and established procedures (7). Cells were plated on Pseudomonas isolation agar (Difco) containing tetracycline and kanamycin. Colonies that were kanamycin resistant and gentamicin sensitive were selected. Replacement of the native smo gene by a smo gene disrupted by the kanamycin resistance marker was confirmed by screening the colonies on LB-agar plates containing 1 mM indole in the presence of air saturated with styrene for styrene monooxygenase (SMO) induction. Native SMO converts indole into indigo, resulting in blue colonies; colonies with inactivated SMO remain white (20).
|
View this table: [in a new window] |
TABLE 2. Oligonucleotide primers used in this study
|
|
|
|---|
smo. Wild-type P. putida S12 degraded p-hydroxystyrene only in the presence of styrene. P. putida S12 C3
smo did not degrade p-hydroxystyrene, in either the presence or absence of styrene. These results suggest that p-hydroxystyrene is oxidized by SMO and that p-hydroxystyrene is not an inducer for smo. Therefore, deletion of the smo gene is not required for stable p-hydroxystyrene production in P. putida S12. This was confirmed by the observation that p-hydroxystyrene was never degraded in the production experiments with strain 427-derived constructs, which have an intact smo gene (data not shown).
Construction of p-hydroxystyrene producing P. putida S12 strains.
Two different strains with an enhanced flux toward L-tyrosine, P. putida S12 C3 and P. putida S12 427, were modified to produce p-hydroxystyrene via L-tyrosine. Since p-coumarate is the direct precursor for p-hydroxystyrene, the degradation of p-coumarate via the p-coumarate catabolic pathway should be blocked for optimal p-hydroxystyrene production. To this end, the first gene of the p-coumarate degradation pathway, fcs (encoding feruloyl-coenzyme A synthetase), was inactivated by homologous recombination in P. putida S12 427 (Table 1), similar to the inactivation of fcs in P. putida S12 C3 (19). The pal and pdc genes were introduced in strains P. putida S12 C3
smo and P. putida S12 427
fcs by transformation of one of the pal-pdc expression plasmids pJNTpalpdc or pJT'Tpalpdc, enabling the conversion of L-tyrosine into p-hydroxystyrene (Fig. 1). Production of p-hydroxystyrene by the resulting four different P. putida S12 constructs was assessed during growth on MMG medium in shake flask cultures (Table 3).
|
View this table: [in a new window] |
TABLE 3. Characteristics of p-hydroxystyrene production by different P. putida S12 strains
|
fcs pJNTpalpdc was selected for further study.
Production of p-hydroxystyrene in a fed-batch fermentation.
In order to increase productivity under controlled conditions, the production of p-hydroxystyrene by strain S12 427
fcs pJNTpalpdc was studied in fed-batch cultures (Fig. 2). p-Hydroxystyrene accumulated to a maximum concentration of 4.5 mM with a Yp/s of 6.7 C-mol%, a biomass (x) to substrate yield (Yx/s) of 50 C-mol%, and a product to biomass yield (Yp/x) of 13 C-mol% (Table 3). Only trace amounts of p-coumarate were observed, and the by-product t-cinnamate accumulated to a final concentration of 0.36 mM. The ammonium concentration increased slightly after the feed was started, likely due to a decreased growth rate caused by increasing p-hydroxystyrene toxicity. The feed rate was adapted to keep the nitrogen concentration below 30 mg liter–1. At all time points, glucose or its corresponding acid metabolites gluconate and 2-ketogluconate were present in the broth at a minimum total concentration of 40 mM. Thus, carbon was always present in large excess to nitrogen.
![]() View larger version (17K): [in a new window] |
FIG. 2. Production of p-hydroxystyrene by P. putida S12 427 fcs pJNTpalpdc in fed-batch cultivation. Concentration p-hydroxystyrene (pHS; ), CDW ( ), and ammonium ( ). The arrow indicates the time that the feed was started. The data presented are from a single representative experiment.
|
p-Hydroxystyrene production in a nitrogen-limited two-phase water-decanol fed-batch fermentation.
In order to maintain product concentrations below inhibitory levels, biphasic fed-batch cultures were performed with P. putida S12 427
fcs pJNTpalpdc using 1-decanol as the second phase. The conditions were comparable to the single-aqueous phase fermentation except for the addition of 500 ml of 1-decanol after 15 h of cultivation (Fig. 3). Also, the feed was concentrated twofold in order to compensate for the volume that the 1-decanol phase occupies in the bioreactor.
![]() View larger version (15K): [in a new window] |
FIG. 3. Production of p-hydroxystyrene by P. putida S12 427 fcs pJNTpalpdc during a two-phase water-1-decanol nitrogen-limited fed-batch fermentation. The total concentration of p-hydroxystyrene (phs tot [ ]; left y axis) calculated as described in the Material and Methods section, concentration of p-hydroxystyrene in the 1-decanol phase (phs dec [ ]; right y axis), and the concentration of p-hydroxystyrene in the aqueous phase (phs aq [ ]; left y axis) are shown. The filled arrow indicated the time that the feed was started, and the open arrow indicates the time that 1-decanol was added. The data presented are from a single representative experiment.
|
The partition coefficient of p-hydroxystyrene in this medium/solvent system (Ps/w) was approximately 120, based on the final concentrations p-hydroxystyrene in the aqueous and 1-decanol phases. In the water phase, only trace amounts of p-coumarate were detected, and t-cinnamate accumulated to a final concentration of 0.55 mM. p-Coumarate, t-cinnamate, and salicylate were not extracted by 1-decanol. The growth-limiting compound during fed-batch fermentation (ammonium) was measured to monitor cell growth since the cell growth rate (µ) is related to the ammonium consumption rate. Accumulation of ammonium indicates that the ammonium consumption rate has fallen below the feeding rate, likely due to a decrease in µ caused by p-hydroxystyrene toxicity. No ammonium was detected during the feed phase, indicating that p-hydroxystyrene did not reach inhibitory concentrations. Glucose, gluconate, and/or 2-ketogluconate was always present throughout the fermentation at a minimum total concentration of 30 mM. The CDW was 2.7 g liter–1 when 1-decanol was added. The presence of 1-decanol made further OD600 measurements impracticable due to emulsion formation. Therefore, the biomass formation was estimated based on the ammonium consumption, resulting in an estimated final biomass concentration of 30 g liter–1. Based on this estimation, the Yp/x is 13 C-mol%. The Yx/s and Yp/s were 33 C-mol% and 4.1 C-mol%, respectively, assuming that glucose was the sole carbon source. However, in a separate experiment P. putida S12 was shown to utilize 1-decanol as a sole carbon source (not shown). Therefore, coutilization of 1-decanol in the biphasic culture cannot be excluded and would serve to reduce the above calculated yield estimates.
|
|
|---|
The biocatalysts derived from strain P. putida S12 C3 are L-phenylalanine auxotrophic, resulting in a negligible production of the by-product t-cinnamate (19), which is advantageous for downstream processing. However, the auxotrophy strongly affected the growth rate of this strain and therefore also the p-hydroxystyrene production rate since growth and production are directly linked. The biocatalysts derived from strain P. putida S12 427 show some t-cinnamate formation but have a higher growth rate, Yp/s and rp,max than strain C3 derivatives (Table 3). The latter three factors were regarded as more important for efficient production, and thus P. putida S12427
fcs pJNTpalpdc was selected for further study.
Despite the high solvent tolerance of P. putida S12, p-hydroxystyrene production exerted negative effects on the host cell system. The Yp/s for p-hydroxystyrene was approximately 1.5-fold lower than for the less toxic product p-coumarate (19; also unpublished data). No accumulation of p-coumarate was observed in shake flask cultures, indicating that the conversion of p-coumarate into p-hydroxystyrene by PDC was not the bottleneck as it was for the E. coli production system (23).
In the fed-batch culture of P. putida S12 427
fcs pJNTpalpdc, growth and production were completely inhibited at the critical concentration of 4.5 mM of p-hydroxystyrene. Ben-Bassat et al. encountered similar problems with their E. coli system but at lower p-hydroxystyrene concentrations. To alleviate product toxicity, they added a second phase of 2-undecanone (Ps/w of 20) (2, 23), resulting in the production of 14.2 mM p-hydroxystyrene in the organic solvent phase. Due to its inherent solvent tolerance, P. putida S12 can tolerate both a higher p-hydroxystyrene concentration and a second phase of the more efficient extractant 1-decanol (Ps/w of 120). This led to the production of 147 mM p-hydroxystyrene in the 1-decanol phase, which is a significant 10-fold improvement compared to the E. coli system.
Although product toxicity could be substantially alleviated by addition of a second phase of 1-decanol, allowing considerably increased productivity and product titers, a clear negative effect of the extractant phase itself was observed on Yp/s. The negative impact of solvents on Yx/s has been extensively studied and can be attributed to both a direct uncoupling effect of the solvent on the proton motive force and the energy demand by RND (resistance-nodulation-cell division)-type solvent extrusion pumps (13, 17). Since biomass and product formation are closely linked, a decreased Yx/s will translate directly into a lower Yp/s, which was underlined by the constant Yp/x of 13 C-mol% in both the aqueous and the biphasic water-solvent fed-batch cultivations. The decreased Yx/s caused by the extractant toxicity may be averted by the physical separation of the aqueous and organic phases by using advanced in situ product removal techniques such as solvent-impregnated resins (32) or membrane extraction (11). This, together with a stable genomic integration of the heterologous pal-pdc construct, would also lead to a more stable process.
The study presented here clearly demonstrates the usefulness of solvent-tolerant biocatalysts for the production of toxic aromatics in combination with integrated product extraction. By further process optimization of the solvent-to-water ratio, the reactor volume, and the solvent selection, the product titers could be significantly increased. Thus, this work may greatly assist the economically viable production of the value-added chemical p-hydroxystyrene from cheap renewable resources, which will be of great environmental as well as economic benefit.
We thank Corjan van den Berg for helpful discussions concerning the product extraction for the two-phase fermentation and Jan Wery for his contribution to the initial phase of this work.
Published ahead of print on 5 December 2008. ![]()
S.V. and N.W. contributed equally to this work. ![]()
Present address: Dyadic Nederland BV, Nieuwe Kanaal 7, 6709 PA Wageningen, The Netherlands. ![]()
|
|
|---|
C. Biotechnol. Bioeng. 98:1219-1229.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»